Abbie VanSickle and Pam Belluck of The New York Times report, “The dramatic dueling rulings by two federal district judges on Friday about access to a widely used abortion pill set up a lower court conflict that legal experts say will almost certainly send the dispute to the Supreme Court.” The first order, from a Texas judge, held that the FDA’s approval of mifepristone, the most commonly used abortion drug in the United States, was improper and should be revoked. The second order, from a Washington state judge, held that access to mifepristone should not be altered. Samuel L. Bray, a law professor at the University of Notre Dame, said, “The two decisions are in conflict and the conflict between them is not sustainable.”